Candriam SCA’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.1M Buy
259,731
+62,470
+32% +$20.2M 0.4% 43
2025
Q4
$59.9M Sell
197,261
-15,307
-7% -$5.01M 0.3% 74
2025
Q3
$72.4M Sell
212,568
-67,718
-24% -$20.6M 0.38% 61
2025
Q2
$67.9M Sell
280,286
-5,607
-2% -$1.38M 0.39% 59
2025
Q1
$77.8M Buy
+285,893
New +$66.8M 0.49% 42
2023
Q2
Sell
-6,033
Closed -$1.2M 882
2023
Q1
$1.2M Hold
6,033
0.01% 676
2022
Q4
$1.33M Buy
6,033
+1,152
+24% +$211K 0.01% 656
2022
Q3
$658K Buy
4,881
+1,557
+47% +$267K ﹤0.01% 786
2022
Q2
$537K Hold
3,324
﹤0.01% 720
2022
Q1
$627K Hold
3,324
﹤0.01% 725
2021
Q4
$901K Sell
3,324
-132,957
-98% -$44.9M 0.01% 676
2021
Q3
$49.5M Buy
136,281
+5,686
+4% +$1.86M 0.34% 71
2021
Q2
$44.8M Sell
130,595
-60,749
-32% -$20.1M 0.31% 73
2021
Q1
$47.5M Sell
191,344
-5
-0% -$1.66K 0.4% 60
2020
Q4
$49.4M Buy
191,349
+27,152
+17% +$7.48M 0.39% 60
2020
Q3
$47M Sell
164,197
-2,079
-1% -$489K 0.44% 46
2020
Q2
$31.3M Buy
166,276
+40,779
+32% +$6.64M 0.33% 72
2020
Q1
$20.3M Buy
125,497
+11
+0% +$1.72K 0.23% 99
2019
Q4
$20.8M Sell
125,486
-50,266
-29% -$8.35M 0.22% 99
2019
Q3
$21.5M Sell
175,752
-58,000
-25% -$7.7M 0.29% 70
2019
Q2
$28.8M Buy
233,752
+50,520
+28% +$6.41M 0.36% 55
2019
Q1
$24.2M Buy
183,232
+35,444
+24% +$4.78M 0.31% 69
2018
Q4
$20.7M Buy
147,788
+47,488
+47% +$6.3M 0.32% 63
2018
Q3
$17.3M Buy
100,300
+58,800
+142% +$9.89M 0.23% 105
2018
Q2
$6.38M Buy
41,500
+6,500
+19% +$1.16M 0.1% 253
2018
Q1
$5.88M Buy
+35,000
New +$4.74M 0.1% 252
2017
Q3
Sell
-55,000
Closed -$2.48M 751
2017
Q2
$2.48M Sell
55,000
-60,000
-52% -$2.36M 0.05% 421
2017
Q1
$4.21M Buy
+115,000
New +$4.19M 0.08% 284

Other funds holding ONC